FY2025 Earnings Estimate for USNA Issued By DA Davidson

USANA Health Sciences, Inc. (NYSE:USNA) – Equities researchers at DA Davidson issued their FY2025 earnings per share (EPS) estimates for USANA Health Sciences in a report released on Tuesday, February 25th. DA Davidson analyst C. Xue anticipates that the company will earn $2.57 per share for the year. DA Davidson currently has a “Neutral” rating and a $38.00 target price on the stock. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. DA Davidson also issued estimates for USANA Health Sciences’ FY2026 earnings at $2.68 EPS.

A number of other equities research analysts have also recently commented on USNA. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th.

USANA Health Sciences Stock Up 3.8 %

NYSE:USNA opened at $33.17 on Thursday. The company has a market capitalization of $632.26 million, a PE ratio of 11.72, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. USANA Health Sciences has a 52-week low of $30.13 and a 52-week high of $50.32. The stock has a fifty day simple moving average of $33.62 and a 200-day simple moving average of $36.61.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The firm had revenue of $213.61 million for the quarter, compared to the consensus estimate of $208.82 million.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Martingale Asset Management L P lifted its holdings in USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after buying an additional 340 shares in the last quarter. KBC Group NV lifted its holdings in shares of USANA Health Sciences by 96.6% in the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after purchasing an additional 519 shares during the last quarter. R Squared Ltd bought a new stake in USANA Health Sciences in the 4th quarter valued at about $28,000. Safe Harbor Fiduciary LLC acquired a new position in shares of USANA Health Sciences during the third quarter worth approximately $30,000. Finally, Exchange Traded Concepts LLC boosted its position in USANA Health Sciences by 11.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock worth $308,000 after acquiring an additional 869 shares during the period. Hedge funds and other institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.